{"id":"https://openalex.org/W382491709","doi":null,"title":"[Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].","display_name":"[Up-regulation of c-myc expression in MCF-7/Adr human breast cancer cells and its association with resistance against doxorubicin].","publication_year":2002,"publication_date":"2002-02-01","ids":{"openalex":"https://openalex.org/W382491709","mag":"382491709","pmid":"https://pubmed.ncbi.nlm.nih.gov/12390804"},"language":"zh","primary_location":{"id":"pmid:12390804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12390804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077855912","display_name":"\u9648\u4fca","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120929","display_name":"Zhujiang Hospital","ror":"https://ror.org/02mhxa927","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210120929"]},{"id":"https://openalex.org/I58200834","display_name":"Southern Medical University","ror":"https://ror.org/01vjw4z39","country_code":"CN","type":"education","lineage":["https://openalex.org/I58200834"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Chen","raw_affiliation_strings":["Departments of Radiotherapy,Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Radiotherapy,Zhujiang Hospital, First Military Medical University, Guangzhou 510282, China","institution_ids":["https://openalex.org/I4210120929","https://openalex.org/I58200834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032063998","display_name":"\u5f20\u79ef\u4ec1","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ya-Wei Yuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Ji-Ren Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ji-Ren Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Dian-Yuan Zhou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dian-Yuan Zhou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1691,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.52942274,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"22","issue":"2","first_page":"124","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.9649999737739563},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.902999997138977},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8090000152587891},{"id":"https://openalex.org/keywords/mcf-7-adr-cells","display_name":"MCF-7/ADR cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gene-upregulation","display_name":"gene upregulation","score":0.7200000286102295},{"id":"https://openalex.org/keywords/chemoresistance-reversal","display_name":"chemoresistance reversal","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.34941285848617554},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3410681486129761}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016271","descriptor_name":"Proto-Oncogene Proteins c-myc","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018432","descriptor_name":"Drug Resistance, Multiple","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:12390804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12390804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA","raw_type":"English Abstract"},{"id":"mag:2417707751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12390804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null},{"id":"mag:382491709","doi":null,"is_oa":false,"landing_page_url":"http://www.cqvip.com/QK/91170X/200202/6281809.html","pdf_url":null,"source":{"id":"https://openalex.org/S4306545097","display_name":"\u5357\u65b9\u533b\u79d1\u5927\u5b66\u5b66\u62a5","issn_l":"1000-2588","issn":["1000-2588","1673-4254"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["ki-jl-1","medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u7b2c\u4e00\u519b\u533b\u5927\u5b66\u5b66\u62a5","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W296045848","https://openalex.org/W590493863","https://openalex.org/W88130240","https://openalex.org/W571597864","https://openalex.org/W621226015","https://openalex.org/W2532486751","https://openalex.org/W2292529380","https://openalex.org/W1520617175","https://openalex.org/W2896953038","https://openalex.org/W912610424"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"the":[3,15,130,143],"expression":[4,33,67,109,126],"of":[5,18,49,69,83,124,132,145,147],"c-myc":[6,19,32,70,104,108,125,138],"in":[7,34,88,112,142],"drug-resistant":[8],"MCF-7/Adr":[9,37,57,89,113,133],"human":[10],"breast":[11],"cancer":[12],"cells":[13,114],"and":[14,40],"counteractive":[16],"effect":[17],"antisense":[20,105],"oligonucleotide":[21],"on":[22],"their":[23,118],"drug-resistance.":[24],"METHODS:":[25],"Flow":[26],"cytometry":[27],"was":[28,51,60,85,92],"performed":[29],"to":[30,62,95],"examine":[31],"multi-drug":[35],"resistant":[36],"cell":[38,43,58,74,120],"line":[39,44,59,75,121],"its":[41,72],"parental":[42],"MCF-7.":[45,122],"The":[46,80],"IC50":[47,81],"value":[48,82],"doxorubicin":[50,84],"evaluated":[52],"by":[53],"MTT":[54],"assay.":[55],"RESULTS:":[56],"shown":[61],"have":[63],"a":[64],"significantly":[65,93],"higher":[66],"rate":[68],"than":[71],"parent":[73,119],"MCF-7":[76],"(70.48%":[77],"vs":[78],"46.02%).":[79],"(22.00+/-1.92)":[86],"micomol/L":[87],"cells,":[90],"which":[91],"decreased":[94],"(9.60+/-1.04)":[96],"micromol/L":[97,103],"(P<0.05)":[98],"after":[99],"coincubation":[100],"with":[101,117],"4":[102],"oligonecleotide.":[106],"CONCLUSION:":[107],"is":[110],"up-regulated":[111],"as":[115],"compared":[116],"Inhibition":[123],"may":[127,139],"partially":[128],"reverse":[129],"resistance":[131],"against":[134],"doxorubicin,":[135],"suggesting":[136],"that":[137],"be":[140],"involved":[141],"mechanism":[144],"drug-resistance":[146],"tumor":[148],"cells.":[149]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}